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Fidelity of chromosome segregation is ensured by a ten-
sion-dependent error correction system that prevents
stabilization of incorrect chromosome–microtubule at-
tachments. Unattached or incorrectly attached chromo-
somes also activate the spindle assembly checkpoint,
thus delaying mitotic exit until all chromosomes are
bioriented. The Aurora B kinase is widely recognized as
a component of error correction. Conversely, its role in the
checkpoint is controversial. Here, we report an analysis of
the role of Aurora B in the spindle checkpoint under
conditions believed to uncouple the effects of Aurora B
inhibition on the checkpoint from those on error correc-
tion. Partial inhibition of several checkpoint and kineto-
chore components, including Mps1 and Ndc80, strongly
synergizes with inhibition of Aurora B activity and dra-
matically affects the ability of cells to arrest in mitosis in
the presence of spindle poisons. Thus, Aurora B might
contribute to spindle checkpoint signalling independently
of error correction. Our results support a model in which
Aurora B is at the apex of a signalling pyramid whose
sensory apparatus promotes the concomitant activation of
error correction and checkpoint signalling pathways.
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Introduction
The metaphase-to-anaphase transition is an irreversible tran-
sition of the cell cycle. Satisfaction of the spindle assembly
checkpoint and subsequent activation of the ubiquitin ligase
anaphase promoting complex/cyclosome (APC/C) ultimately
lead to the destruction of cyclin B and securin, causing
mitotic exit and sister chromatid separation (Musacchio and
Salmon, 2007). To be accurate, chromosome segregation
requires that all sister chromatid pairs are bioriented, which
implies that the two sister chromatids of each chromosome
are bound to opposite spindle poles.
Kinetochores link chromosomes to microtubules
(Cheeseman and Desai, 2008; Santaguida and Musacchio,
2009). The so-called KMN network (from the initials of its
Knl1, Mis12 and Ndc80 subcomplexes), a 10-subunit assem-
bly, provides the microtubule-binding interface of kineto-
chores (Cheeseman et al, 2006; DeLuca et al, 2006).
Kinetochores host an error correction mechanism that clears
improper kinetochore–microtubule attachments. The obser-
vation that syntelic attachments (both kinetochores bound to
the same pole) are intrinsically unstable, unless tension is
artificially exercised on them, led to propose that tension is
required to stabilize kinetochore–microtubule attachments
(Nicklas and Koch, 1969).
Aurora B (Ipl1 in Saccharomyces cerevisiae), a serine/
threonine (S/T) kinase, is a subunit of a chromosome pas-
senger complex that is recruited to centromeres during mi-
tosis (Carmena et al, 2009). Aurora B is a crucial component
of a tension sensor at centromeres and kinetochores and its
depletion or inhibition results in the accumulation of mal-
attachments (Biggins and Murray, 2001; Tanaka et al, 2002).
Kinetochores also host the spindle assembly checkpoint,
whose effector, the mitotic checkpoint complex (MCC),
prevents APC/C activation until all chromosomes have
bioriented (reviewed in Musacchio and Salmon, 2007).
Checkpoint components include kinases, such as Bub1,
BubR1, Mps1 and Prp4, as well as protein–protein interaction
components, such as Mad1, Mad2 and the Rod–Zwilch–Zw10
complex (RZZ) (Musacchio and Salmon, 2007). Within the
MCC, Mad2, Bub3 and BubR1 form a complex with Cdc20, an
APC/C co-activator required for targeting crucial APC/C
substrates at the metaphase–anaphase transition. When en-
gaged in the MCC, Cdc20 is unable to target its substrates, so
that entry into anaphase becomes inhibited (Musacchio and
Salmon, 2007).
The exact relationship between tension-dependent error
correction and checkpoint status is elusive (Khodjakov and
Rieder, 2009; Nezi and Musacchio, 2009; Santaguida and
Musacchio, 2009; Khodjakov and Pines, 2010; Lampson and
Cheeseman, 2010; Maresca and Salmon, 2010). It has been
proposed that the spindle checkpoint is exquisitely sensitive
to microtubule attachment, regardless of whether the attach-
ment is under tension (Khodjakov and Rieder, 2009;
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Khodjakov and Pines, 2010). Within this scheme, error cor-
rection and the checkpoint are distinct molecular entities,
monitoring lack of tension or attachment, respectively, and
the role of Aurora B in the checkpoint is indirect: error
correction, which is Aurora B dependent, generates condi-
tions, likely including unattached kinetochores, which in turn
activate an Aurora B-independent checkpoint (Khodjakov
and Rieder, 2009; Khodjakov and Pines, 2010) (model 1,
Figure 1A). In an alternative view, the spindle checkpoint
and error correction are viewed as co-regulated phenomena,
both of which require Aurora B (Santaguida and Musacchio,
2009; Maresca and Salmon, 2010). According to this view,
tensionless kinetochores (including unattached or incorrectly
attached kinetochores) signal to the SAC in an Aurora B-
dependent manner. Concomitantly, Aurora B activity is
required to prevent premature stabilization of kinetochore–
microtubule attachments, thus protecting from errors (model
2, Figure 1B).
Regardless of which camp is chosen, it is generally agreed
that microtubules are required for creating attachment and
tension, so that in their absence (e.g. in the presence of
microtubule-depolymerizing agents such as nocodazole), the
checkpoint cannot be satisfied. This allowed the development
of a test to assess models 1 and 2. The original implementa-
tion of this test was utilized to conclude that Ipl1/Aurora B is
not involved in the checkpoint response from unattached
kinetochores in S. cerevisiae (Biggins and Murray, 2001)
(Figure 1C and D). In brief, the goal of the test is to combine
inhibition of Aurora B with microtubule depolymerization by
spindle poisons. In case of model 1, this predicts that the
checkpoint should work normally under these conditions,
because the function of Aurora B in the creation of unat-
tached kinetochores during error correction is bypassed by
microtubule depolymerization. Conversely, loss of potency of
the checkpoint response when inhibiting Aurora B in the
presence of unattached kinetochores would confirm an in-
trinsic role in the checkpoint independently of error correc-
tion (Figure 1C and D). Despite the availability of this assay,
however, the controversy continued to flourish, largely be-
cause the precise conditions to neutralize the effects from
impaired error correction on the checkpoint response when
inhibiting Aurora B have not been standardized, and the
results accumulated apparently in support of each of the
two competing hypotheses (Biggins and Murray, 2001;
Kallio et al, 2002; Ditchfield et al, 2003; Hauf et al, 2003;
Petersen and Hagan, 2003; King et al, 2007; Vader et al, 2007;
Vanoosthuyse and Hardwick, 2009).
Recently, however, it was shown that a rigorous assess-
ment of whether Aurora B is implicated in checkpoint signal-
ling through the test in Figure 1 requires that microtubules
are completely removed, which is only true at very high
concentrations of microtubule-depolymerizing drugs (Yang
et al, 2009). By definition, the checkpoint cannot be satisfied
at very high concentrations of microtubule-depolymerizing
agents (as there are no microtubules left), providing a con-
dition for assessing the role of Aurora B in the checkpoint
independently from its effects on error correction. At
suboptimal concentrations of spindle poisons, residual mi-
crotubules contribute to checkpoint satisfaction when the
error correction function of Aurora B is inhibited, therefore
accelerating mitotic exit (Yang et al, 2009).
The study concluded that previous positive evidence sup-
porting an involvement of Aurora B in the checkpoint in-
dependently of error correction was biased by insufficient
concentrations of microtubule-depolymerizing agents (Yang
et al, 2009). In a previous characterization of the effects of
hesperadin, potent small-molecule inhibitor of Aurora B, on
checkpoint duration, an inhibitor concentration of 100 nM
was typically used (Ditchfield et al, 2003; Hauf et al, 2003).
At this concentration of hesperadin, there is a strong depen-
dence of mitotic duration on nocodazole concentration, with
cells living mitosis much more rapidly at low nocodazole
concentrations than at high-nocodazole concentrations (Hauf
et al, 2003; Yang et al, 2009).
An undemonstrated assumption in many studies with
small-molecule inhibitors, including those with Aurora B, is
that the enzymatic activity of the target is completely inhib-
ited at the typical concentrations of inhibitors used, or any-
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Figure 1 Schematic description of role of Aurora B in error correc-
tion and the spindle checkpoint. (A) Model 1: Aurora B is required
for error correction. Correction generates unattached kinetochores,
or incompletely attached kinetochores, re-activating the checkpoint.
Aurora B does not contribute to checkpoint signalling from unat-
tached kinetochores. Thus, in model 1 Aurora B contributes ex-
trinsically to the checkpoint by generating, upon correction, a
condition that supports the checkpoint, such as unattached kine-
tochores. SAC, spindle assembly checkpoint. (B) Model 2: In this
scheme, Aurora B is additionally required for the checkpoint
response from unattached kinetochores, that is it is an intrinsic
component of the checkpoint. (C) A test for model 1. When Aurora
B is inhibited, error correction is impaired, and therefore the
checkpoint response from an incorrect attachment cannot fire. If a
spindle poison is added to create an unattached kinetochore in-
dependently of error correction, the checkpoint response is normal
even when Aurora B has been inhibited. (D) The same test is
applied to model 2. In this case, unattached kinetochores cannot
bypass inhibition of Aurora B, because Aurora B is also required for
the checkpoint response from unattached kinetochores.
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way that residual activity is insufficient to sustain the normal
function of the enzyme. Here, we decided to adopt the
rigorous framework offered by the addition of high-nocoda-
zole concentrations to re-evaluate the effects of Aurora B
inhibitors on the spindle assembly checkpoint. Our results
are consistent with a role of Aurora B in checkpoint signalling
independently of error correction.
Results and discussion
Effects on mitotic arrest from inhibiting Aurora B in low
or high nocodazole
It has been argued that the duration of the mitotic arrest in
the presence of 100 nM hesperadin (Hauf et al, 2003) may
depend on the concentration of nocodazole (Yang et al,
2009). We confirmed this result using a range of nocodazole
concentrations (Figure 2A). At low nocodazole concentra-
tions, HeLa cells concomitantly treated with 100 nM hesper-
adin left mitosis significantly more rapidly than at high-
nocodazole concentrations. These results are consistent
with the hypothesis that inhibition of error correction in the
presence of residual microtubules reduces the duration of the
mitotic arrest by satisfying the spindle checkpoint (Yang et al,
2009).
As expected, the increase in the duration of mitotic arrest
saturates at high concentrations of nocodazole (Figure 2A).
Based on these observations, and in line with Yang et al
(2009), we opted to use nocodazole at 3.3 mM as a working
concentration under which it can be safely assumed that
checkpoint satisfaction is virtually impossible due to com-
plete depolymerization of microtubules. At this concentration
of nocodazole, tubulin appears completely diffuse (Yang et al,
2009; Santaguida et al, 2010). Furthermore, the duration of
the mitotic arrest in the presence of 100 nM hesperadin
increased very modestly at higher concentrations of nocoda-
zole in comparison to the duration of 3.3 mM, suggesting that
this concentration largely satisfies the requirement that mi-
crotubules are depolymerized (Figure 2A). We also reasoned
that growing concentrations of nocodazole might increase the
risk of unspecific interference with other cellular processes
(however, we demonstrate in Supplementary Figure S4 that
our conclusions remain valid even at higher concentrations of
nocodazole or in the presence of a different microtubule-
depolymerizing agent). Based on these considerations, we
consider 3.3 mM nocodazole an appropriate concentration
for testing the role of Aurora B on checkpoint signalling
independently of error correction.
We therefore compared the duration of the checkpoint-
dependent mitotic arrest in HeLa cells treated with 0.33 and
3.3 mM nocodazole at different concentrations of hesperadin.
As a control for checkpoint override, we used reversine, a
bona fide ATP-competitive inhibitor of the spindle checkpoint
kinase Mps1 (Santaguida et al, 2010). At both concentra-
tions of nocodazole, we observed a strong dose-dependent
effect on the duration of the mitotic arrest (Supplementary
Table SI; Figure 2B). At 100 nM hesperadin, the checkpoint
response was significantly but not dramatically affected,
with cells undergoing override at B700 min rather than
41100 min in control cells at high-nocodazole concentrations
(Figure 2B; Supplementary Table SI) (at which point control
cells usually undergo slippage, whereby they exit M-phase
spontaneously despite the continued presence of checkpoint-
activating offences (Brito and Rieder, 2006)). Yang et al
(2009) observed even milder effects on checkpoint duration
in the presence of 100 nM hesperadin at 3.2 mM nocodazole
in RPE1 cells. At 0.5 and 1.0 mM hesperadin, however, we
observed a very strong reduction in the duration of the
checkpoint, both in low and high nocodazole. The reduction
was inferior but close to that observed with 1 mM reversine
(a concentration causing complete checkpoint abrogation,
Supplementary Table SI and Figure 2B).
Altogether, these results support the contention that high
doses of nocodazole are required to rigorously assess the role
of Aurora B (Yang et al, 2009). Furthermore, the results
provide an initial indication that Aurora B activity is required
for the checkpoint response in the absence of microtubules.
Effects on kinetochore localization of checkpoint
proteins from inhibiting Aurora B
Lack of kinetochore localization of Mad2 or Mad1 (the Mad2
kinetochore receptor, displaying identical kinetochore locali-
zation timing as Mad2) strongly correlates with checkpoint
weakening or impairment. Because kinetochore localization
of Mad2 is impaired at 0.3 mM nocodazole, but normal at
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Figure 2 Effects of hesperadin and reversine on the spindle check-
point. (A) HeLa cells were treated as indicated in the scheme. STA,
single thymidine arrest. Cells were monitored by time-lapse video
microscopy as they transited through mitosis. The histogram re-
ports the time in mitosis (measured as the time of a cell’s rounding
up) at the indicated nocodazole concentrations and at a fixed
concentration of hesperadin of 100 nM. At the same hesperadin
concentration, there were significant differences in the time spent in
mitosis depending on nocodazole concentrations. Values represent
mean and s.d. and were calculated from at least 50 cells for each
condition. (B) Cells were filmed like in (A) in the presence of the
indicated concentrations of inhibitors and nocodazole.
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3.2 mM in the presence of 100 nM hesperadin (Yang et al,
2009), Rieder and colleagues concluded that Mad2 was
absent from kinetochores upon inhibition of Aurora B be-
cause residual microtubules in low nocodazole were ‘strip-
ping’ Mad2 from kinetochores (Yang et al, 2009), the normal
route through which Mad2 is removed from kinetochores
(Musacchio and Salmon, 2007).
We found that at 100 nM hesperadin, whether Mad1 is
found at kinetochores depends on the protocol of drug
exposure. When hesperadin was added after prolonged no-
codazole arrest, Mad1 localization at 3.3 mM nocodazole, but
not at 0.33 mM, was normal, as reported previously for Mad2
(Yang et al, 2009) (Figure 3A). However, if hesperadin was
added together with nocodazole prior to entry into mitosis,
Mad1 failed to localize to kinetochore at both low and high-
nocodazole concentrations (Figure 3B). Based on these results,
we surmise that there is probably a less stringent requirement
for Aurora B activity to retain Mad1 and Mad2 at kinetochores
than there is for their initial recruitment to kinetochores.
Outer kinetochore organization is not grossly affected
by Aurora B inhibitors
Results so far are consistent with the hypothesis that Aurora
B is implicated in checkpoint signalling regardless of its
proven function in error correction. Further confirming this
idea, hesperadin, like reversine, promoted MCC dissociation
Figure 3 Effects of hesperadin and reversine on the spindle checkpoint. (A) Kinetochore localization of the checkpoint protein Mad1 in HeLa
cells. The scheme of the experiment is shown (numbers above arrows indicate hours). Cycling cells were treated with 0.3 or 3.3mM nocodazole
for 12 h. MG132 was first added and then hesperadin. After 90 min, cells were fixed and processed for indirect immunofluorescence. CREST is a
kinetochore marker. MG132 was added to retain cells in mitosis in the presence of hesperadin. Bar¼ 5mm (B) Kinetochore localization of
Mad1 was evaluated as in (A), but hesperadin and nocodazole were added before cells entered mitosis. DTA, double thymidine arrest.
(C) Immunoprecipitation of Cdc20 and analysis of interacting proteins at the indicated concentration of reversine or hesperadin. HeLa cells
were arrested in nocodazole for 12 h. After shake-off, MG132 was added, and after 300 the indicated inhibitors were added for further 90 min in
the continued presence of MG132. Cells were then harvested and processed for immunoprecipitation. (D, E) The phosphorylation state of
BubR1 and Bub1 was evaluated in mitotic cells treated with nocodazole and the indicated concentration of hesperadin or reversine. Cells were
treated as discussed in (C). (F) Concentrations of inhibitors required for the indicated percent inhibitions of Aurora B and Mps1 were calculated
as explained in Materials and methods.
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in a dose-dependent manner (Figure 3C). Mitotic phosphor-
ylation of BubR1 and Bub1 was also dramatically reduced
(Figure 3D and E), indicating that both Aurora B and Mps1
contribute to their mitotic phosphorylation.
In the experiments in Figure 3A and B, reduced or absent
Mad1 localization in high nocodazole is unlikely to be caused
by Mad1 ‘stripping’, as the latter requires microtubules
(Hoffman et al, 2001). As an alternative explanation, we
asked if the inability of Mad1 to reach the kinetochore was
due to a defect in kinetochore assembly when Aurora B is
inhibited. Indeed, it has been proposed that Aurora B con-
tributes to outer kinetochore assembly (Emanuele et al,
2008). Other studies, however, confute the idea that Aurora
B is important for kinetochore assembly (Liu et al, 2010;
Santaguida et al, 2010; Welburn et al, 2010). In agreement
with the latter studies, we found that the levels of kineto-
chore-localized Ndc80 and Knl1, two components of the
so-called KMN network that are crucially implicated in the
recruitment of the checkpoint proteins, appear to localize to
kinetochores essentially normally even at the high concen-
trations of hesperadin that prevent Mad1 localization in high
nocodazole (Supplementary Figure S1). Kinetochore localiza-
tion of Ndc80 relies on core kinetochore components, includ-
ing CENP-I and the Mis12 complex (Hori et al, 2003; Kline
et al, 2006; Liu et al, 2006; McAinsh et al, 2006). That
kinetochore localization of Ndc80 is largely unaffected in-
dicates that the core structure of the kinetochore is preserved
in the presence of Aurora B inhibitors. In summary, although
we cannot rule out that the localization of additional kine-
tochore components, not considered in our analysis, is
affected when Aurora B is inhibited, we suspect that reduced
localization of checkpoint components is unlikely to be
caused by an overt defect in the assembly of the kinetochore.
Further evidence in support of this contention is discussed in
the context of Figure 6.
What is the ‘right’ concentration of an Aurora B
inhibitor?
Results so far indicate that hesperadin has negative conse-
quences on the checkpoint even when microtubules have
been completely depolymerized to exclude effects from in-
hibiting error correction. Thus, our results challenge the
contention that Aurora B influences the checkpoint exclu-
sively through error correction (Yang et al, 2009). We note
that this contention was based on the undemonstrated
assumption that 100 nM hesperadin is sufficient to completely
abrogate Aurora B activity, but our results on the duration
of the mitotic arrest at different doses of hesperadin
(Supplementary Table SI; Figure 2B) suggest that this might
not be the case. This issue is further addressed in experiments
presented in Figures 4–6.
On the other hand, using hesperadin (and reversine) at
relatively high concentrations, up to 1mM, raises significant
concerns about the specificity of its effects. To address such
concerns, we determined that hesperadin is inactive against
a set of checkpoint and mitotic kinases (Supplementary
Figure S2; the specificity of reversine has been discussed
(Santaguida et al, 2010)). Furthermore, in discussing this
objection, it should be noted that checkpoint signals from a
single unattached kinetochore are sufficient to maintain a
mitotic arrest (Rieder et al, 1995), strongly suggesting that the
checkpoint network is designed to achieve amplification. The
exact topology of the checkpoint network is unknown, so that
the way in which signal amplification is achieved remains
unclear. But we argue that because of the amplification
properties of the network, it may be necessary to achieve
very significant inhibition of its activity before a penetrant
checkpoint phenotype is observed when chromosomes are
unattached. Indeed, small residual amounts (2–5%) of the
checkpoint kinase Bub1 are compatible with a checkpoint
response in nocodazole, whereas its full depletion causes
checkpoint failure (Meraldi and Sorger, 2005; Perera et al,
2007). Similarly, while depletion of the subunits of the Ndc80
complex causes a checkpoint defect, small residual amounts
are compatible with strong mitotic arrest in nocodazole
(Martin-Lluesma et al, 2002; DeLuca et al, 2003; McCleland
et al, 2003; Meraldi et al, 2004).
To provide a quantitative framework to these ideas, we
predicted the inhibitory effects of hesperadin or reversine on
Aurora B or Mps1 after measuring their catalytic parameters.
With 2 mM ATP, a concentration approximating the ATP con-
centration in cells (Traut, 1994), we predict that 0.18–1.9 mM
reversine or 0.13–1.4mM hesperadin might be respectively
required to achieve inhibition of Mps1 or Aurora B activity
from 90 to 99% (Figure 3F; Supplementary Figure S3). Factors
such as limited inhibitor permeability, inhibitor modification
and competition from other active sites, likely further decrease
the active inhibitor concentration in cells. Thus, that doses of
hesperadin or reversine as high as 1–2mM are required for
checkpoint override is expected and unsurprising.
Mps1 and Aurora B inhibitors synergize
To build a stronger case for a direct role of Aurora B in the
checkpoint, we asked if such a role could be exacerbated
under conditions of partial inhibition of other checkpoint
components. For this, we initially tested the effects from
combining Aurora B and Mps1 inhibitors on the checkpoint
response. At 200 nM, hesperadin or reversine each mildly but
significantly affected the timing of the checkpoint response to
high nocodazole (Figure 4A; Supplementary Table SI). When
the two inhibitors were combined, each at 100 nM, a dramatic
checkpoint defect was exposed (Figure 4A). Similar results
were obtained in the osteosarcoma U2OS cell line and the
non-transformed immortalized epithelial cell line hTERT-
RPE1 (Figure 4A). The same effect was also observed at
10mM nocodazole or 15 mM colchicine, ruling out an
off-target effect of the spindle poison on the checkpoint, or
an effect of residual microtubules on checkpoint satisfaction
(Supplementary Figure S4). The combination of 100 nM
hesperadin and 100 nM reversine caused a dramatic decrease
in the levels of MCC, indicative of its disassembly and of
checkpoint override (Figure 4B).
Hesperadin has relatively modest selectivity for Aurora B
(Hauf et al, 2003), leaving open the possibility that its effects
on the checkpoint are due to inhibition of other Aurora family
members, Aurora A and Aurora C. To address this concern,
we carried out inhibitor combination experiments with addi-
tional Aurora inhibitors, including ZM447439, reported to
have 20-fold Aurora B/Aurora A selectivity and five-fold
Aurora B/Aurora C selectivity (Ditchfield et al, 2003;
Girdler et al, 2006), and AZD1152, reported to have 41000-
fold Aurora B/Aurora A selectivity and 417-fold Aurora
B/Aurora C selectivity (Mortlock et al, 2007). As an alter-
native Mps1 inhibitor, we used Mps1-IN-1 (Kwiatkowski
Aurora B is directly implicated in spindle checkpoint
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et al, 2010). In all cases, we observed very dramatic effects
from the combined inhibition of Aurora B and Mps1 (Figure
4C and D).
The localization experiments in Figure 3A and B suggest
the possibility that the effects of Aurora B inhibitors on the
checkpoint response might depend on whether the Aurora B
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inhibitors are added prior to entry into mitosis or after entry
into mitosis. Specifically, these results suggest the possibility
that Aurora B is required to initiate the checkpoint response,
but not to maintain it. To test this idea, we collected mitotic
cells by shake-off 6 h after the addition of nocodazole and
added hesperadin, reversine or their combination. The results
in Figure 4E demonstrate that under these conditions, inhi-
bitor-treated cells exited mitosis prematurely, indicating that
Aurora B is not only required for instating checkpoint signal-
ling, but also for maintaining it. When cells were harvested
after a 12-h mitotic arrest, we noted that the ability of Aurora
B and Mps1 inhibitors, or their combination, to drive mitotic
exit was comparatively reduced, although not abrogated
(Figure 4F). It is difficult to explain these observations, but
we speculate that they might be related to defined physiolo-
gical changes in cells facing a prolonged arrest with high
concentrations of spindle poisons, and possibly finalized to
prevent re-entry in the cell cycle.
Formal analysis using Loewe’s additivity hypothesis
The experiments above suggest the possibility that combining
Aurora B and Mps1 inhibitors has a more than additive
adverse effect on the checkpoint. To explore this system-
atically, we analysed the effects from combining hesperadin
Figure 5 Combination of Mps1 and Aurora B inhibition has synergistic effects on checkpoint. (A) HeLa cells were released from a single
thymidine arrest (STA) and treated with 3.3mM nocodazole and the indicated inhibitors. Time spent in mitosis was evaluated based on mitotic
rounding up of cells by time-lapse video microscopy. Values represent the mean (s.d. are collected in Supplementary Table SI) and were
calculated from at least 50 cells for each condition. (B) Kinetochore localization of the spindle checkpoint proteins Mad1 and Zwilch
in HeLa cells was evaluated at 3.3mM nocodazole, upon addition of the indicated inhibitors and of MG132 (to suppress mitotic exit in
the presence of the inhibitors). Cells were fixed and processed for indirect immunofluorescence. Bar¼ 5mm. (C) Quantification of Mad1
and Zwilch localization from the experiment in (B). Values are calculated from at least 90 cells from three independent experiments.
(D) Immunoprecipitation of Cdc20 and analysis of interacting proteins at the indicated concentration of reversine, hesperadin or their
combination. (E) Loewe additivity analysis of the experiment in (A). For the three indicated hesperadin:reversine ratios, the fractional
inhibition was plotted against the inhibitor concentration. Fractional inhibition was calculated and the curves for reversine (red), hesperadin
(green) and their combination (blue) were fitted with a Hill function (see Materials and methods for details). Based on the additivity formula
(Chou, 1991): 1¼C1/C1xþC2/C2x (see Materials and methods), we plotted the hypothetical additivity curves for different inhibitors
combination ratios (1:1, 2:1, 1:2). We also fitted the experimental combination curves for the same ratios and compared them with the
hypothetical additivity curves. If the experimental combination curve lies on the left of the additivity curve, synergy is present. Combining
hesperadin and reversine produces synergy when the two drugs are used in the three different combination ratios (see also Supplementary
Figure S5). To represent the combination data quantitatively, we also plotted the theoretical combination curves for the three ratios 1:1, 2:1, 1:2
(Chou, 1991; Chou, 2006). On the x axis of these plots we have the fractional inhibition and on the y axis the combination index. We show that
the CI iso1 for different effect levels and for the three combination ratios (see Supplementary Figure S5). Strong synergy is observed (CIo0.3)
for a large range of fractional inhibition. As an example, in order to produce an effect of about 85%, we should use about 560 nM reversine
or41000 nM hesperadin; but, if we use them in 1:1 combination, about 55 nM reversineþ 55 nM hesperadin are sufficient. In this case the CI is
about 0.13.
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and reversine at different ratios in high nocodazole
(Figure 5A). As little as 10 nM hesperadin reduced the dura-
tion of the checkpoint arrest to one third at 100 nM reversine
(from 754 to 256 min), whereas 25 nM hesperadin caused
dramatic checkpoint failure (Figure 5A; Supplementary Table
SI). In isolation, 100 nM reversine or 25 nM hesperadin had
negligible effects on the localization of Mad1 or Zwilch to
kinetochores in high nocodazole, whereas their combination
evicted them from kinetochores (Figure 5B and C) and caused
significant MCC disassembly (Figure 5D). Being caused by
very low hesperadin concentrations, these dramatic effects
are likely due to specific Aurora B inhibition.
We adopted the Loewe additivity hypothesis (Loewe, 1953)
and the Chou and Talalay method (Chou and Talalay, 1981,
1984; Chou, 1991) to investigate the effect of hesperadin and
reversine combinations on the timing of mitotic exit from
3.3 mM nocodazole-induced arrest. At several relative ratios
(three of which are shown in Figure 5E), the effects on the
checkpoint from combining the two inhibitors denoted a very
small combination index (CI), indicative of very strong
synergy between the inhibitors (CIo1 indicates synergy and
CI¼ 0.3 indicates strong synergy) (Figure 5E; Supplementary
Figure S5).
Synergy between partial outer kinetochore defects and
Aurora B inhibition
We performed additional experiments by exploiting partial or
complete depletions of checkpoint proteins through RNAi
(Figure 6A). RNAi-based depletion of MPS1 caused complete
checkpoint override (Figure 6B), but we found it difficult to
modulate the levels of Mps1 with sufficient robustness to
achieve partial depletion (not shown). Partial depletion of
Aurora B by RNAi (Figure 6B), on the other hand, was
compatible with a long-term arrest in high nocodazole, but
not when reversine was used at 250 nM. Also in this case
there was a very strong synergistic effect (Figure 6B;
Supplementary Table SI).
The KMN network complex is implicated in the recruit-
ment of all checkpoint proteins (with the exclusion of Aurora
B) (Santaguida and Musacchio, 2009). Within the KMN net-
work, the Ndc80 complex has been implicated in a pathway
of recruitment of the RZZ complex, Mad1 and Mad2
(Martin-Lluesma et al, 2002). Consistently, RNAi-based
depletion of Ndc80 and Nuf2, two components of the
Ndc80 complex, results in complete inhibition of the check-
point response (Meraldi et al, 2004). On the other hand,
suboptimal depletions result in a strong mitotic arrest even in
the absence of spindle poisons, possibly because a residual
checkpoint response is mounted in the presence of residual
Ndc80 complex (Martin-Lluesma et al, 2002; DeLuca et al,
2003). We confirmed that partial RNAi-based depletion of
Nuf2 was compatible with prolonged checkpoint arrest in
high nocodazole (Figure 6C). Addition of hesperadin at
100 nM caused a dramatic effect on the duration of the
checkpoint response, with cells being completely unable to
arrest in mitosis in high nocodazole (Figure 6C).
Thus, even defects in kinetochore assembly can sensitize
cells to Aurora B inhibition and cause a checkpoint defect in
high nocodazole. These results further argue against the
possibility, discussed above, that Aurora B inhibitors can,
by themselves, dramatically affect kinetochore assembly.
Conclusions
The work presented here lends credit to the hypothesis
that Aurora B has a role in the spindle checkpoint indepen-
dently of error correction. This hypothesis has been
formulated several times in the past (Kallio et al, 2002;
Ditchfield et al, 2003; Hauf et al, 2003; Petersen and Hagan,
2003; King et al, 2007; Vader et al, 2007; Vanoosthuyse and
Hardwick, 2009), and regularly challenged on the ground that
it is difficult to identify conditions in which the well-estab-
lished influence on error correction from inhibiting Aurora B
can be reliably excluded from the analysis of the role of
Aurora B in the checkpoint (for recent discussions,
see Khodjakov and Rieder, 2009; Nezi and Musacchio,
2009; Santaguida and Musacchio, 2009; Khodjakov and
Pines, 2010; Lampson and Cheeseman, 2010; Maresca and
Salmon, 2010).
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Figure 6 Synergistic effects from inhibiting Aurora B and other
checkpoint and kinetochore proteins. (A) HeLa cells were depleted
of Nuf2 (a subunit of the Ndc80 complex), Mps1 or Aurora B by
RNAi. Depletion of Nuf2 also destabilizes the Ndc80 subunit of the
complex (Meraldi et al, 2004). (B, C) HeLa cells were released from
a double thymidine arrest and treated with 3.3 mM nocodazole and
the indicated inhibitors in combination with the indicated RNAi-
based depletions. Cells were analysed by time-lapse video micro-
scopy. Time spent in mitosis was evaluated based on mitotic
rounding up of cells. Values represent mean and s.d. and were
calculated from at least 50 cells for each condition.
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Our results question the contention that Aurora B is
exclusively an extrinsic checkpoint component whose influ-
ence on the checkpoint is merely a consequence of its
participation in error correction. If error correction and the
spindle checkpoint were molecularly distinct, then the inhibi-
tion of error correction should only influence the ability to
correct improper attachments, but not the checkpoint re-
sponse, as predicted for the test of model 1 (Figure 1C). We
show instead, under conditions in which inhibition of error
correction is not expected to have detrimental effects on the
intensity of the checkpoint response, due to the presence of
very high concentrations of microtubule depolymerizers, that
the spindle checkpoint response is very severely impaired
when Aurora kinase activity becomes inhibited, as expected
for model 2 (Figure 1D).
Several previous studies have suggested the possibility
that Aurora kinase activity is completely (Biggins et al,
1999; Yang et al, 2009) or partially (Ditchfield et al, 2003;
Hauf et al, 2003) dispensable for the checkpoint response to
unattached kinetochores. We suspect that the observations
on which these conclusions were based might have been
caused by residual kinase activity of mutant proteins or
incomplete inhibition with small-molecule inhibitors. For
instance, our results strongly argue that 100 nM hesperadin
achieves significant but incomplete inhibition of Aurora B
activity, in line with the partial inhibition of the spindle
checkpoint observed in HeLa cells under these conditions
(Hauf et al, 2003).
Previously, partial Aurora B and Bub1 inhibition has been
shown to have synergistic effects on checkpoint inhibition
(Meraldi and Sorger, 2005; Morrow et al, 2005). The
results were interpreted as reflecting the existence of two
distinct arms of the checkpoint response, a tension-depen-
dent arm relying on Aurora B and an attachment sensitive
arm relying on Bub1. We show that Aurora B and Mps1
strongly synergize in the checkpoint. Because complete in-
hibition of Aurora B, Bub1 or Mps1 in isolation leads to a
checkpoint defect in high nocodazole (with high doses of
hesperadin in the case of Aurora B, with high doses of
reversine or RNAi in the case of Mps1, with RNAi in the
case of Bub1), these kinases appear to operate within a single
pathway, and synergy results from inhibiting this pathway
concomitantly at distinct nodes. Understanding the topology
of the checkpoint network that explains these results is the
challenge for future studies.
By showing that Aurora B might contribute to checkpoint
signalling independently of error correction, we provide
the basis for a better molecular understanding of the
checkpoint sensory apparatus. The ability of Aurora B to
phosphorylate substrates in the kinetochore depends on
their distance from Aurora B, which changes during the
course of attachment (Liu et al, 2009). In this respect,
Aurora B might contribute to the ability of kinetochores of
monitoring intrakinetochore stretch, an increase of B35 nm
in the distance between inner and outer kinetochore compo-
nents when tension is built (Maresca and Salmon, 2009;
Uchida et al, 2009). The exact molecular changes imposed
by intrakinetochore stretch, and the way Aurora B might
measure them, remain a matter for conjecture (Liu et al,
2009; Maresca and Salmon, 2009, 2010; Santaguida and
Musacchio, 2009). We note that the physical distances asso-
ciated with intrakinetochore stretch, B35 nm, resemble the
molecular scale of the proteins involved (e.g. the Ndc80
complex has a long axis of 55–60 nm). This suggests that
the pool of Aurora B responsible for the checkpoint response
might reside very closely to its substrates. The very high local
concentration of checkpoint-relevant kinase-substrate pairs at
unattached kinetochores might explain why very little resi-
dual Aurora kinase activity is compatible with the checkpoint
response.
Materials and methods
Cell culture and synchronization
HeLa cells and U2OS cells were grown in Dulbecco’s modified Eagle
medium (Euroclone) supplemented with 10% fetal bovine serum
(Hyclone) and 2 mM L-glutamine. hTERT-RPE1 cells were grown in
Minimal Essential Medium: HAM’s F12K Medium 1:1 supplemented
with 10% fetal bovine serum (Hyclone), 15 mM HEPES, 0.5 mM
sodium pyruvate. Nocodazole (at concentrations indicated in each
figure or figure legend), thymidine (2 mM) and Colchicine (15 mM)
were obtained from Sigma-Aldrich. MG132 (Calbiochem) was used
at 10mM throughout.
RNAi
Previously described siRNA duplexes were used to repress Aurora B
(Ditchfield et al, 2003), Mps1 (Jelluma et al, 2008) and Nuf2
(Meraldi et al, 2004). siRNA duplexes were purchased from
Dharmacon Research and transfected using Lipofectamine 2000
reagent (Invitrogen) according to the manufacturer’s instructions.
Immunofluorescence microscopy and antibodies
for immunofluorescence
Immunofluorescence microscopy was carried out on cells fixed
using PFA 4% in PBS, permeabilized using Triton X-100 0.1% in
PBS, then treated with BSA 4% in PBS as blocking agent and
incubated with the proper antibodies diluted in BSA 4% in PBS.
Incubation with primary and secondary antibodies was performed
as described previously (Taylor et al, 2001). Antibodies against
Mad1, BubR1, Bub1, Cenp-C and Zwilch have been described
(Taylor et al, 2001; De Antoni et al, 2005; Trazzi et al, 2009; Civril
et al, 2010). Additional antibodies for immunofluorescence were
anti-Centromeric antibodies (working dilution 1:50, Antibodies
Inc.) and mouse anti-HEC1 (human NDC80) (working dilution
1:1000, Genetex Clone 9G3.23). Cy3- and Cy5-labelled and Alexa-
488-labelled secondary antibodies for immunofluorescence were
from Jackson Immunoresearch and Invitrogen, respectively. DNA
was stained with 40,6-diamidino-2-phenylindole. The coverslips
were mounted using Mowiol mounting media. Cells were imaged
using a Leica TCS SP2 confocal microscope equipped with a  63
NA 1.4 objective lens using the LCS 3D software (Leica). Images
were imported in Adobe Photoshop CS3 (Adobe Systems Inc.) and
levels were adjusted.
Antibodies for immunoblotting
The following antibodies were used for immunoblotting: rabbit
anti-Aurora B (working dilution 1:1000, Abcam); rabbit anti-Bub1
(working dilution 1:2000, Abcam); mouse anti-BubR1 (working
dilution 1:1000, Transduction Laboratories, BD); mouse anti-Mps1
(working dilution 1:2000, Upstate); rabbit anti-pH3 Ser10 (working
dilution 1:1000, Abcam); rabbit anti-Cdc20 (working dilution 1:500,
Santa Cruz); mouse anti-Hec1 (human Ndc80) (working dilution
1:1000, Genetex Clone 9G3.23); mouse anti-Bub3 (working dilution
1:2000, Transduction lab, BD); mouse anti-Mad2 (clone AS55-A12)
was produced at the IFOM-IEO campus monoclonal antibody
facility (De Antoni et al, 2005).
Immunoprecipitations
HeLa cells were harvested by trypsinization and lysed in lysis buffer
(50 mM HEPES pH 7.5, 150 mM NaCl, 1% glycerol, 1% Triton
X-100, 5 mM EGTA, 1.5 mM MgCl2, 10 mM Na3VO4, 50 mM NaF,
10 mM Na4-pyrophosphate, protease inhibitor cocktail (Roche)) for
20 min on ice and then sonicated. Cell lysates were centrifuged
for 45 min at 13 000 r.p.m. at 41C. Equivalent amounts of soluble
protein lysates were incubated with mouse anti-Cdc20 (2mg
antibody/mg lysate—Santa Cruz) for 12 h at 41C followed by
Aurora B is directly implicated in spindle checkpoint
S Santaguida et al
The EMBO Journal VOL 30 | NO 8 | 2011 &2011 European Molecular Biology Organization1516
incubation with protein G Sepharose beads (Pharmacia) at 41C for
2 h. The beads were washed three times in lysis buffer and proteins
were eluted in SDS sample buffer.
Video microscopy
Live cell imaging was performed using an IX70 inverted microscope
(Nikon) equipped with an incubation chamber (Solent Scientific)
maintained at 371C in an atmosphere of 5% CO2. Movies were
acquired using a  20 magnification objective controlled by ScanR
software (Olympus).
In vitro kinase assays
In vitro kinase assays were performed and analysed as previously
described (Santaguida et al, 2010).
ADP luminescent assay
Kinetic analyses of Aurora B45344:INCENP835903 (Santaguida et al,
2010) and Mps11857 (full-length human MPS1, Invitrogen) were
performed using a luminometric kinase assay varying the concen-
tration of ATP using the ADP-Glo reagents (Promega). In all, 5 nM
Aurora B kinase was assayed in a 10-ml reaction containing 25 mM
Tris (pH 7.6), 10 mM MgCl2, 150 mM NaCl, 1 mM EDTA, 1 mM DTT,
varying concentrations of ATP and 5 mM histone H3 (Roche) and
followed for 15 min. In all, 50 nM Mps1 kinase was assayed in a 10-
ml reaction containing 12.5 mM Tris (pH 7.6), 10 mM MgCl2, 1 mM
EGTA, 0.01% Triton X-100, varying concentrations of ATP and 6mM
MAD1:MAD2 complex as substrate and followed for 30 min. The
overall reaction rate was determined as the slope of the linearly
increasing phase of the reaction. Each data point was collected in
duplicate and kinetic parameters were obtained using GraphPad
Prism v3.0 software.
Additivity analysis
To define fractional inhibition, we considered 70 min spent as a
mitotically rounded-up cell as corresponding to a 100% drug effect
(no delay in mitotic exit) and about 1100 min as a 0% effect
(maximum duration of mitosis, corresponding to no drug addition).
The effect is therefore intended as the percent reduction of time
required for mitotic exit. So, if a drug (or a combination of drugs)
produces a mitotic exit time equal to x minutes, we say that the
effect produced is ((1100–70)–(x–70))/(1100–70)¼ (1030–(x–70))/
1030. In order to apply Chou and Talalay method (Chou and Talalay,
1981, 1984; Chou, 1991), we first fitted dose–effect curves for single
inhibitors with Hill functions of the form E¼Cn/(knþCn); here
E is the percent effect deriving from a drug concentration equal to C
of a single drug and k and n are coefficients to be fitted. From the
Chou model (Chou, 2006) we have that, if Cx1 and Cx2 are the
doses of drugs 1 and 2 (respectively) that produce an effect equal to
x when used alone and if C1 and C2 are the doses of the same drugs
in combination that give rise to that effect, the combination is
additive if the quantity C1/C1xþC2/C2x is equal to one. This
means that the total dose of the two drugs in combination simply is
equal to equi-effective doses of the two drugs used alone; in other
words, no total dose sparing advantages derive from using the
drugs together. The quantity C1/C1xþC2/C2x is called the ‘CI’
and is a way of comparing the effect of a drug combination with
the effects of single inhibitors. A CI value which is o1 indicates a
synergistic effect deriving from the combination and for a certain
effect level; on the contrary, CI41 indicates antagonism. A
value CIo0.3 is usually considered as an indicator of a strong
synergistic effect.
Determination of the Kd for hesperadin, ZM447439 and
reversine
To determine the degree of kinase activity inhibition (defined as the
percent reduction of the initial maximal velocity) at different
inhibitor concentrations, reported in Figure 3F, we carried out a
simulation of the dose–response curves for the three kinase-
inhibitor pairs shown in Figure 3F. For this, we generated a system
of ordinary differential equations that describes both the phosphor-
ylation reaction and the effect of the inhibitor. The equations are
based on two simplifications. In the first we assume that most of the
enzyme is bound to the substrate, which is justified by the fact that
in the experiment we use (enzyme)¼ 5 nM and (substrate)¼ 5 mM.
As a consequence of this assumption, we neglect the free enzyme.
The second simplification is the standard quasi-steady state
approximation for the enzyme–substrate and enzyme–inhibitor
complexes. Given these two assumptions, we introduce the
following variables: I, inhibitor; A, ATP; P, phosphorylated
substrate (which equals ADP); and E, enzyme (which is always
bound to the substrate). Moreover, we keep track of the following
complexes: E–A, formed by the substrate-bound enzyme and ATP,
and E–I, formed by the substrate-bound enzyme and the inhibitor.
We adopt the following reaction scheme
(1) EþA2E–A (kon, koff)
(2) E–A-EþP (kcat)
(3) Eþ I2E–I (kon_i, koff_i)
which can be translated in the system of algebraic-differential
equations:
d½P
dt
¼ kcatðE : AÞ
0 ¼ ðAt  P  E : AÞðEt  E : A E : IÞ  KM  E : A
0 ¼ ðIt  E : IÞðEt  E : A E : IÞ  Kd  E : I
where KM¼ (koffþ kcat)/kon and Kd¼ koff_i/kon_i. KM and kcat were
measured for the three enzymes considered: for Aurora B
KM¼ 16.5mM and kcat¼ 62 per min; for Mps1 KM¼ 4.9mM and
kcat¼ 3.2 per min (Supplementary Figure S3A–D). The dose–
response curves were calculated by letting the reaction proceed in
the presence of initial concentrations of enzyme (Et)¼ 5 nM and ATP
(At)¼ 50mM (where the subscript t stands for ‘total’) for 1 h, the same
duration of the reported experimental inhibition curves (Santaguida
et al, 2010). Different points of the dose–response curves were
calculated by increasing the amount of total inhibitor (It). The amount
of phosphorylated substrate (i.e. ADP produced) was plotted against
the total amount of inhibitor. The only unknown parameter in the
system of equations is the Kd of the inhibitor for the enzyme’s active
site. To get an estimate for Kd we imposed to the simulation that at
60 min, the initial substrate has been halved in the presence of a
concentration of inhibitor equal to the experimentally calculated IC50.
All other points shown in the curves in Supplementary Figure S3E–G
were not fitted but simulated based on this Kd. All numerical
simulations were carried out with XPP-AUT, a free software program
developed by Professor Bard Ermentrout (Department of Mathe-
matics, University of Pittsburgh).
Determination of the predicted concentrations of inhibitors
in vivo
To predict the amount of inhibitors required for inhibiting Aurora B
and Mps1 in vivo, we assumed a concentration of ATP in cells of
2 mM (Traut, 1994) and cellular concentrations of each kinase of
1 nM. Moreover, we assumed, as done for the measurements
in vitro, that the substrates of the enzymes are more abundant than
the enzymes (i.e. no free enzymes). We then used the differential-
algebraic equations described above to calculate the initial
rate of the reaction in the presence of different doses of inhibitors,
using the kinetic parameters measured in vitro. We took the initial
rate of the reaction without inhibitors as 100%, and we identified
the concentration of inhibitors that would reduce it to 50, 10, 5
and 1%.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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